c-CbI negatively regulates platelet activation by Glycoprotein VI
Research output: Contribution to journal › Article
Background: The adapter protein c-Cbl has emerged as having a potential role in negative regulation of immune receptor signaling. The major platelet- signaling receptor for collagen, glycoprotein VI (GpVI), is associated with the Fe receptor (FcR) gamma-chain, and signals through a similar pathway to immune receptors. c-Cbl is tyrosine-phosphorylated in response to stimulation of GpVI, whereas phosphorylation of c-Cbl in thrombin-activated platelets is dependent on fibrinogen binding to the integrin GpIIb/IIIa. Objective: To investigate the role of c-Cbl in platelet signaling. Methods: Murine platelets lacking functional c-Cbl or Src family kinases were analyzed. Results: Phosphorylation of c-Cbl through GpVI is reduced in murine platelets deficient in the Src-family kinases Fyn and Lyn, demonstrating that they lie upstream of c-Cbl phosphorylation. Phosphorylation of several proteins of the GpVI-signaling pathway, including the FcR gamma-chain, Syk and phospholipase Cgamma2 (PLCgamma2), is increased in the absence of c-Cbl. In line with this, aggregation is potentiated in response to the GpVI-specific collagen-related peptide (CRP) after a slight delay. A delay in potentiation is also seen in response to stimulation by thrombin. Conclusions: These observations demonstrate that c-Cbl negatively regulates platelet responses to GpVI agonists and to thrombin, with the latter effect possibly being mediated downstream of GpIIb/IIIa. c-Cbl may play a physiological role in helping to prevent unwanted platelet activation in vivo.
|Number of pages||8|
|Journal||Journal of Thrombosis and Haemostasis|
|Publication status||Published - 1 Nov 2003|
- glycoprotein VI, c-Cbl